NCT03314831View on ClinicalTrials.gov

The Role of Myristic Acid in Serum for Early Diagnosis of Sepsis and Comparison With Selected Biomarkers of Sepsis

CompletedOBSERVATIONAL

Enrollment

282

Participants

Timeline

Start Date

October 24, 2017

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2022

Conditions

Sepsis SyndromeSystemic Inflammatory Response Syndrome

Trial Locations (1)

14059

Department of Anesthesiology and Intensive Care, First Faculty of Medicine, Charles University and Thomayer Hospital, Prague

All Listed Sponsors

lead

Charles University, Czech Republic

OTHER

NCT03314831 - The Role of Myristic Acid in Serum for Early Diagnosis of Sepsis and Comparison With Selected Biomarkers of Sepsis | Biotech Hunter | Biotech Hunter